• 1. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 2. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 3. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 4. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 5. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Recent Advances in the Study of 3-Pyridinecarboxylicacid, 6-(2-thienyl)-, methyl ester (CAS: 179408-53-8) in Chemical Biology and Pharmaceutical Research

The compound 3-Pyridinecarboxylicacid, 6-(2-thienyl)-, methyl ester (CAS: 179408-53-8) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research briefing aims to provide an up-to-date overview of the latest findings related to this compound, including its synthesis, biological activity, and potential applications in drug development.

Recent studies have highlighted the role of 3-Pyridinecarboxylicacid, 6-(2-thienyl)-, methyl ester as a key intermediate in the synthesis of novel heterocyclic compounds. Its structural framework, which combines a pyridine ring with a thienyl group, offers a versatile scaffold for the development of bioactive molecules. Researchers have explored its utility in the design of kinase inhibitors, antimicrobial agents, and anti-inflammatory compounds, demonstrating its broad applicability in medicinal chemistry.

One of the most notable advancements in the study of this compound is its potential as a modulator of protein-protein interactions (PPIs). A 2023 study published in the Journal of Medicinal Chemistry revealed that derivatives of 3-Pyridinecarboxylicacid, 6-(2-thienyl)-, methyl ester exhibit high affinity for specific protein targets involved in cancer cell proliferation. The study employed computational docking and molecular dynamics simulations to elucidate the binding mechanisms, providing valuable insights for future drug design efforts.

In addition to its therapeutic potential, recent research has also focused on optimizing the synthetic routes for 3-Pyridinecarboxylicacid, 6-(2-thienyl)-, methyl ester. A team of chemists reported a novel catalytic method that significantly improves the yield and purity of the compound, as detailed in a 2022 article in Organic Letters. This advancement is expected to facilitate large-scale production and further exploration of its biological activities.

Despite these promising developments, challenges remain in fully understanding the pharmacokinetic and pharmacodynamic properties of 3-Pyridinecarboxylicacid, 6-(2-thienyl)-, methyl ester. Ongoing studies are investigating its metabolic stability, toxicity profiles, and potential off-target effects to ensure its suitability for clinical applications. Preliminary results from in vivo models suggest that the compound has a favorable safety profile, but further validation is required.

In conclusion, 3-Pyridinecarboxylicacid, 6-(2-thienyl)-, methyl ester (CAS: 179408-53-8) represents a promising candidate for drug discovery and development. Its unique structural features, combined with its diverse biological activities, make it a valuable tool for researchers in the chemical biology and pharmaceutical fields. Future studies should focus on translating these findings into practical applications, such as the development of novel therapeutics for unmet medical needs.

• 179408-54-9(6-(2-Thienyl)nicotinic Acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)